Many studies’ results have shown that SPAG6 plays a critical role in tumor involvement and progression, especially in myelodysplastic syndrome (MDSC), the common hematological malignancies, and SPAG6 levels were significantly higher than those in solid tumors (Barretina et al., 2019). Here, SPAG6 is linked to myelodysplastic syndrome.